Birgit Girshick insider trades
Open-market stock purchases and sales by Birgit Girshick, Chief Executive Officer at Charles River Laboratories International, Inc, from SEC Form 4 filings since Feb 23, 2018.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +69%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 19, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | — |
| Aug 11, 2026 | CRL Charles River Laboratories International, Inc | Sold | $1.8M |
| Aug 11, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | — |
| Jun 5, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | — |
| May 31, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $68.3K |
| May 30, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $218K |
| May 29, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | $1.8M |
| May 27, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $37.9K |
| May 26, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $60.3K |
| Mar 4, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | — |
| Jan 30, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | — |
| Jan 30, 2026 | CRL Charles River Laboratories International, Inc | Sold (not open market) | $648K |
Companies traded
- CRL Charles River Laboratories International, Inc: 2 buys, 135 sales, last Aug 19, 2026